Mirtazapin-Mepha Teva 45 mg, Filmtabletten - 30 Swissmedic Key 61460016 Registration Holder Mepha Pharma AG Name Mirtazapin-Mepha Teva 45 mg, Filmtabletten Date of registration 06.09.2011 Introduction of Sequence 06.09.2011 ATC-Classification Mirtazapine (N06AX11) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.06. Show package size 30 Index Therapeuticus (Swissmedic) 01.06. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680614600167 Medication Code Synthetika Pharmacode Disponibility
Composition mirtazapinum 45 mg, lactosum monohydricum 305.4 mg, amylum pregelificatum, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium max. 0.78 mg, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 8000, pro compresso obducto. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Mirtazapine 45 mg
Inactive agents Dose additional_information Amylum Pregelificatum Carmellosum Natricum Conexum E 171 color. Hypromellosum Überzug Lactose Monohydrate 305.4 mg Macrogol 8000 Magnesii Stearas Pro Compresso Obducto Silica Colloidalis Anhydrica
Source Data was imported : 12.03.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
